Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for C Frank Bennett. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at C Frank Bennett har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:IONS / Ionis Pharmaceuticals, Inc. | EVP, Chief Scientific Officer | 82 679 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av C Frank Bennett. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Internkjøp IONS / Ionis Pharmaceuticals, Inc. - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i IONS / Ionis Pharmaceuticals, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel IONS / Ionis Pharmaceuticals, Inc. - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i IONS / Ionis Pharmaceuticals, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av C Frank Bennett som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-09-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 000 | 82 679 | −6,77 | 59,60 | −357 581 | 4 927 404 |
2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | −12 891 | 88 679 | −12,69 | 61,50 | −792 796 | 5 453 758 |
2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −33 909 | 101 570 | −25,03 | 60,62 | −2 055 564 | 6 157 173 |
2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 46 800 | 135 479 | 52,77 | 53,77 | 2 516 436 | 7 284 706 | |
2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 88 679 | −5,34 | 49,14 | −245 700 | 4 357 686 |
2025-09-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 213 | 93 679 | 0,23 | 27,71 | 5 902 | 2 595 845 | |
2025-08-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 93 466 | −9,67 | 43,98 | −439 776 | 4 110 410 |
2025-08-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 10 000 | 103 466 | 10,70 | 32,60 | 326 000 | 3 372 992 | |
2025-03-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 320 | 93 466 | 0,34 | 28,21 | 9 028 | 2 636 816 | |
2025-02-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 327 | 93 146 | −1,40 | 32,46 | −43 079 | 3 023 854 | |
2025-02-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
A - Award | 3 607 | 94 473 | 3,97 | ||||
2025-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −6 752 | 90 866 | −6,92 | 32,90 | −222 114 | 2 989 128 | |
2025-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 18 011 | 97 618 | 22,62 | ||||
2024-09-04 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 885 | 79 047 | −2,33 | 49,52 | −93 337 | 3 914 060 | |
2024-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 177 | 79 607 | 0,22 | 38,64 | 6 839 | 3 076 094 | |
2024-03-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 383 | 79 462 | 0,48 | 34,42 | 13 185 | 2 735 479 | |
2024-02-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 853 | 79 079 | −2,29 | 49,52 | −91 752 | 3 915 644 | |
2024-02-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
A - Award | 3 609 | 80 932 | 4,67 | ||||
2024-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −6 745 | 77 323 | −8,02 | 50,42 | −340 063 | 3 898 394 | |
2024-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 18 314 | 84 068 | 27,85 | ||||
2023-12-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −16 113 | 65 754 | −19,68 | 49,29 | −794 211 | 3 241 021 | |
2023-12-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 16 113 | 81 867 | 24,50 | 47,34 | 762 789 | 3 875 584 | |
2023-12-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −6 500 | 65 754 | −9,00 | 49,64 | −322 643 | 3 263 858 | |
2023-12-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 500 | 72 254 | 9,89 | 47,34 | 307 710 | 3 420 504 | |
2023-12-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −8 610 | 65 754 | −11,58 | 50,19 | −432 110 | 3 299 996 | |
2023-12-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 8 610 | 74 364 | 13,09 | 47,34 | 407 597 | 3 520 392 | |
2023-12-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −14 002 | 65 754 | −17,56 | 49,21 | −689 085 | 3 235 971 | |
2023-12-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 14 002 | 79 756 | 21,29 | 47,34 | 662 855 | 3 775 649 | |
2023-09-29 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 460 | 65 754 | −6,35 | 46,50 | −207 390 | 3 057 561 |
2023-09-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 180 | 70 214 | 0,26 | 30,56 | 5 500 | 2 145 564 | |
2023-03-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 383 | 70 034 | 0,55 | 30,52 | 11 687 | 2 137 088 | |
2023-02-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 813 | 69 651 | −2,54 | 40,57 | −73 560 | 2 826 006 | |
2023-02-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
A - Award | 3 609 | 71 464 | 5,32 | ||||
2023-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −6 978 | 67 855 | −9,32 | 38,89 | −271 356 | 2 638 705 | |
2023-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 19 417 | 74 833 | 35,04 | ||||
2022-09-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 183 | 55 416 | 0,33 | 28,97 | 5 301 | 1 605 291 | |
2022-03-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 346 | 55 233 | 0,63 | 28,37 | 9 817 | 1 567 126 | |
2022-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
M - Exercise | −18 842 | 24 444 | −43,53 | ||||
2022-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −6 726 | 54 887 | −10,92 | 30,12 | −202 587 | 1 653 196 | |
2022-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 18 842 | 61 613 | 44,05 | ||||
2022-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
A - Award | 14 435 | 43 286 | 50,03 | ||||
2022-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Performance Restricted Stock Units |
A - Award | 10 826 | 10 826 | |||||
2022-01-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 28 869 | 28 869 | |||||
2021-09-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 151 | 42 771 | 0,35 | 33,80 | 5 103 | 1 445 489 | |
2021-03-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 112 | 42 620 | 0,26 | 44,54 | 4 988 | 1 898 295 | |
2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −15 520 | 29 641 | −34,37 | ||||
2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 20 822 | 20 822 | |||||
2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −5 488 | 42 508 | −11,43 | 61,28 | −336 305 | 2 604 890 | |
2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 15 520 | 47 996 | 47,79 | ||||
2021-01-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 46 850 | 46 850 | |||||
2020-12-08 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −7 947 | 0 | −100,00 | ||||
2020-12-08 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 947 | 32 476 | −19,66 | 51,04 | −405 615 | 1 657 575 |
2020-12-08 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 7 947 | 40 423 | 24,47 | 39,87 | 316 847 | 1 611 665 |
2020-12-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −7 053 | 7 947 | −47,02 | ||||
2020-12-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 053 | 32 476 | −17,84 | 51,32 | −361 960 | 1 666 668 |
2020-12-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 7 053 | 39 529 | 21,72 | 39,87 | 281 203 | 1 576 021 |
2020-11-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −15 000 | 15 000 | −50,00 | ||||
2020-11-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −15 000 | 32 476 | −31,59 | 46,77 | −701 600 | 1 519 010 |
2020-11-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 15 000 | 47 476 | 46,19 | 39,87 | 598 050 | 1 892 868 |
2020-09-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 112 | 32 476 | 0,35 | 44,46 | 4 979 | 1 443 721 | |
2020-06-29 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −15 000 | 32 364 | −31,67 | 59,77 | −896 505 | 1 934 299 |
2020-06-29 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 15 000 | 47 364 | 46,35 | 39,87 | 598 050 | 1 888 403 |
2020-03-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 169 | 32 364 | 0,52 | 43,16 | 7 295 | 1 396 927 | |
2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −11 711 | 23 549 | −33,21 | ||||
2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 21 612 | 21 612 | |||||
2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −4 162 | 32 195 | −11,45 | 62,06 | −258 294 | 1 998 022 | |
2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 11 711 | 36 357 | 47,52 | ||||
2020-01-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 48 626 | 48 626 | |||||
2019-07-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 118 | 24 646 | 0,48 | 45,70 | 5 393 | 1 126 433 | |
2019-02-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 9 013 | 0 | −100,00 | ||||
2019-02-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −9 013 | 24 528 | −26,87 | 58,29 | −525 368 | 1 429 737 |
2019-02-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 9 013 | 33 541 | 36,75 | 14,69 | 132 401 | 492 717 |
2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −7 822 | 14 463 | −35,10 | ||||
2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 20 797 | 20 797 | |||||
2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −2 818 | 24 400 | −10,35 | 58,26 | −164 177 | 1 421 544 | |
2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 822 | 27 218 | 40,33 | ||||
2019-01-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 46 800 | 46 800 | |||||
2019-01-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 128 | 19 524 | 0,66 | 36,45 | 4 665 | 711 611 | |
2018-11-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 12 500 | 9 013 | −358,47 | ||||
2018-11-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 500 | 19 396 | −39,19 | 49,54 | −619 245 | 960 870 |
2018-11-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 500 | 31 896 | 64,45 | 14,69 | 183 625 | 468 552 |
2018-08-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 12 487 | 21 513 | 138,34 | ||||
2018-08-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 13 | 0 | −100,00 | ||||
2018-08-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 487 | 19 396 | −39,17 | 45,00 | −561 915 | 872 820 |
2018-08-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 487 | 31 883 | 64,38 | 14,69 | 183 434 | 468 361 |
2018-08-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −13 | 19 396 | −0,07 | 45,00 | −585 | 872 820 |
2018-08-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 13 | 19 409 | 0,07 | 7,25 | 94 | 140 715 |
2018-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 282 | 19 396 | 1,48 | 35,42 | 9 988 | 686 997 | |
2018-05-11 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 12 500 | 13 | −100,10 | ||||
2018-05-11 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 500 | 19 114 | −39,54 | 45,00 | −562 500 | 860 130 |
2018-05-11 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 500 | 31 614 | 65,40 | 7,25 | 90 625 | 229 202 |
2018-02-01 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 12 500 | 12 513 | 96 153,85 | ||||
2018-02-01 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 500 | 19 114 | −39,54 | 52,50 | −656 260 | 1 003 500 |
2018-02-01 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 500 | 31 614 | 65,40 | 7,25 | 90 625 | 229 202 |
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 696 | 19 114 | −12,36 | 51,76 | −139 545 | 989 341 | |
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −6 663 | 10 148 | −39,63 | ||||
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 12 137 | 12 137 | |||||
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 663 | 21 810 | 43,99 | ||||
2018-01-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 54 619 | 54 619 | |||||
2018-01-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 106 | 15 147 | 0,70 | 42,76 | 4 532 | 647 610 | |
2017-10-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −12 250 | 0 | −100,00 | ||||
2017-10-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 250 | 15 041 | −44,89 | 65,00 | −796 250 | 977 665 |
2017-10-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 250 | 27 291 | 81,44 | 10,29 | 126 052 | 280 824 |
2017-07-26 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 12 250 | −44,94 | ||||
2017-07-26 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 15 041 | −39,93 | 59,29 | −592 900 | 891 781 |
2017-07-26 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 25 041 | 66,48 | 10,29 | 102 900 | 257 672 |
2017-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 253 | 15 041 | 1,71 | 40,66 | 10 286 | 611 499 | |
2017-03-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 22 250 | −18,35 | ||||
2017-03-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 14 788 | −25,27 | 55,00 | −275 000 | 813 340 |
2017-03-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 19 788 | 33,81 | 10,29 | 51 450 | 203 619 |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −623 | 14 788 | −4,04 | 46,29 | −28 839 | 684 537 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −512 | 13 817 | −3,57 | 46,29 | −23 701 | 639 603 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −733 | 13 018 | −5,33 | 46,29 | −33 931 | 602 603 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −553 | 11 876 | −4,45 | 46,29 | −25 598 | 549 740 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 594 | 4 779 | −25,01 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 311 | 2 620 | −33,35 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 875 | 1 875 | −50,00 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 415 | 0 | −100,00 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 7 537 | 7 537 | |||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 594 | 15 411 | 11,54 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 311 | 14 329 | 10,07 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 875 | 13 751 | 15,79 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 415 | 12 429 | 12,85 | ||||
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 45 225 | 45 225 | |||||
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 211 | 11 014 | 1,95 | 20,76 | 4 380 | 228 618 | |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −22 805 | 0 | −100,00 | ||||
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −17 805 | 10 803 | −62,24 | 38,54 | −686 205 | 416 348 |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 17 805 | 28 608 | 164,82 | 11,27 | 200 662 | 322 412 |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 10 803 | −31,64 | 34,08 | −170 400 | 368 166 |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 15 803 | 46,28 | 11,27 | 56 350 | 178 100 |
2016-11-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 22 805 | −17,98 | ||||
2016-11-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 10 803 | −31,64 | 34,00 | −170 000 | 367 302 |
2016-11-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 15 803 | 46,28 | 11,27 | 56 350 | 178 100 |
2016-07-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 213 | 10 803 | 2,01 | 20,76 | 4 421 | 224 238 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −522 | 10 590 | −4,70 | 41,46 | −21 640 | 439 021 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −747 | 9 801 | −7,08 | 41,46 | −30 967 | 406 305 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −564 | 8 673 | −6,11 | 41,46 | −23 383 | 359 572 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −277 | 7 822 | −3,42 | 41,46 | −11 484 | 324 284 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 311 | 3 931 | −25,01 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 875 | 3 750 | −33,33 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 415 | 1 415 | −50,00 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −694 | 0 | −100,00 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 6 373 | 6 373 | |||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 311 | 11 112 | 13,38 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 875 | 10 548 | 21,62 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 415 | 9 237 | 18,09 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 694 | 8 099 | 9,37 | ||||
2016-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 38 240 | 38 240 | |||||
2016-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 89 | 7 405 | 1,22 | 47,71 | 4 246 | 353 296 | |
2015-12-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −3 909 | 0 | −100,00 | ||||
2015-12-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 909 | 7 316 | −34,82 | 58,85 | −230 045 | 430 547 |
2015-12-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 909 | 11 225 | 53,43 | 14,47 | 56 563 | 162 426 |
2015-12-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −4 000 | 3 909 | −50,58 | ||||
2015-12-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 000 | 7 316 | −35,35 | 56,00 | −224 000 | 409 696 |
2015-12-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 11 316 | 54,67 | 14,47 | 57 880 | 163 743 |
2015-11-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 7 909 | −38,73 | ||||
2015-11-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 7 316 | −40,60 | 64,00 | −320 000 | 468 224 |
2015-11-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 12 316 | 68,34 | 14,47 | 72 350 | 178 213 |
2015-11-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 12 909 | −27,92 | ||||
2015-11-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 7 316 | −40,60 | 56,00 | −280 000 | 409 696 |
2015-11-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 12 316 | 68,34 | 14,47 | 72 350 | 178 213 |
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 87 | 7 316 | 1,20 | 48,59 | 4 227 | 355 455 | |
2015-03-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −9 000 | 17 909 | −33,45 | ||||
2015-03-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −9 000 | 7 229 | −55,46 | 71,01 | −639 090 | 513 331 |
2015-03-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 9 000 | 16 229 | 124,50 | 14,47 | 130 230 | 234 834 |
2015-03-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −6 000 | 26 909 | −18,23 | ||||
2015-03-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 7 229 | −12,15 | 71,00 | −71 000 | 513 259 |
2015-03-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 8 229 | 13,83 | 14,47 | 14 470 | 119 074 |
2015-03-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 7 229 | −40,89 | 69,80 | −349 020 | 504 613 |
2015-03-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 12 229 | 69,17 | 14,47 | 72 350 | 176 954 |
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −714 | 7 229 | −8,99 | 67,96 | −48 526 | 491 312 | |
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −539 | 6 068 | −8,16 | 67,96 | −36 633 | 412 406 | |
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −265 | 5 192 | −4,86 | 67,96 | −18 010 | 352 869 | |
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 875 | 5 625 | −25,00 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 415 | 2 830 | −33,33 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −694 | 694 | −50,00 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 5 242 | 5 242 | |||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 875 | 7 943 | 30,90 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 415 | 6 607 | 27,25 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 694 | 5 457 | 14,57 | ||||
2015-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 31 457 | 31 457 | |||||
2015-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 136 | 4 763 | 2,94 | 30,05 | 4 086 | 143 116 | |
2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 4 627 | −30,18 | 40,55 | −81 100 | 187 625 |
2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 6 627 | 43,22 | 15,38 | 30 760 | 101 923 |
2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 6 627 | 43,22 | 15,38 | 30 760 | 101 923 |
2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 4 627 | −17,77 | 40,53 | −40 530 | 187 532 |
2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 5 627 | 21,61 | 15,38 | 15 380 | 86 543 |
2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 4 627 | −30,18 | 40,50 | −81 000 | 187 394 |
2014-07-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 291 | 4 627 | 6,71 | 30,20 | 8 788 | 139 738 | |
2014-06-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −11 200 | 5 000 | −69,14 | ||||
2014-06-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 4 336 | −53,56 | 36,54 | −182 715 | 158 450 |
2014-06-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 9 336 | 115,31 | 15,38 | 76 900 | 143 588 |
2014-06-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 200 | 4 336 | −58,85 | 36,97 | −229 195 | 160 289 |
2014-06-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 200 | 10 536 | 142,99 | 15,38 | 95 356 | 162 044 |
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −265 | 4 336 | −5,76 | 47,08 | −12 476 | 204 143 | |
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −539 | 3 906 | −12,13 | 47,08 | −25 377 | 183 899 | |
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −695 | 1 388 | −33,37 | ||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 415 | 4 245 | −25,00 | ||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 7 500 | 7 500 | |||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 695 | 4 601 | 17,79 | ||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 415 | 4 445 | 46,70 | ||||
2014-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 45 000 | 45 000 | |||||
2014-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 164 | 3 030 | 5,72 | 24,20 | 3 969 | 73 324 | |
2013-12-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 16 200 | −38,17 | ||||
2013-12-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 550 | 2 866 | −61,35 | 39,90 | −181 545 | 114 353 |
2013-12-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 550 | 7 416 | 158,76 | 15,38 | 69 979 | 114 058 |
2013-12-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 640 | 2 866 | −55,95 | 39,94 | −145 382 | 114 468 |
2013-12-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 640 | 6 506 | 127,01 | 15,38 | 55 983 | 100 062 |
2013-12-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 810 | 2 866 | −38,71 | 39,92 | −72 255 | 114 411 |
2013-12-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 810 | 4 676 | 63,15 | 15,38 | 27 838 | 71 917 |
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 26 200 | −27,62 | ||||
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 2 866 | −77,72 | 35,02 | −350 200 | 100 367 |
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 12 866 | 348,92 | 15,38 | 153 800 | 197 879 |
2013-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 36 200 | −21,65 | ||||
2013-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 2 866 | −77,72 | 30,22 | −302 250 | 86 625 |
2013-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 12 866 | 348,92 | 15,38 | 153 800 | 197 879 |
2013-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 756 | 2 866 | 35,83 | 9,20 | 6 953 | 26 359 | |
2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −6 145 | 0 | −100,00 | ||||
2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −23 800 | 0 | −100,00 | ||||
2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 145 | 2 110 | −74,44 | 22,26 | −136 794 | 46 971 |
2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 145 | 8 255 | 291,23 | 11,12 | 68 332 | 91 796 |
2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −23 800 | 2 110 | −91,86 | 22,26 | −529 812 | 46 971 |
2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 23 800 | 25 910 | 1 127,96 | 6,81 | 162 078 | 176 447 |
2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −30 000 | 6 145 | −83,00 | ||||
2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −30 000 | 2 110 | −93,43 | 22,51 | −675 153 | 47 486 |
2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 30 000 | 32 110 | 1 421,80 | 11,12 | 333 600 | 357 063 |
2013-02-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 34 000 | 34 000 | |||||
2013-02-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 5 660 | 5 660 | |||||
2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −309 | 2 110 | −12,77 | 14,00 | −4 326 | 29 540 | |
2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −695 | 2 083 | −25,02 | ||||
2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 695 | 2 419 | 40,31 | ||||
2013-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 447 | 1 724 | 35,00 | 8,87 | 3 967 | 15 299 | |
2012-07-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 23 800 | −17,36 | ||||
2012-07-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 500 | 0 | −100,00 | ||||
2012-07-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 1 277 | −79,66 | 13,51 | −67 550 | 17 252 |
2012-07-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 6 277 | 391,54 | 6,81 | 34 050 | 42 746 |
2012-07-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 500 | 1 277 | −81,16 | 13,51 | −74 305 | 17 252 |
2012-07-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 500 | 6 777 | 430,70 | 6,84 | 37 620 | 46 355 |
2012-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −6 000 | 5 500 | −52,17 | ||||
2012-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 000 | 1 277 | −82,45 | 12,91 | −77 460 | 16 486 |
2012-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 000 | 7 277 | 469,85 | 6,84 | 41 040 | 49 775 |
2012-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 648 | 1 277 | 103,02 | 6,13 | 3 971 | 7 826 | |
2012-03-07 |
|
4/A | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 25 013 | 25 013 | |||||
2012-03-07 |
|
4/A | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 324 | 629 | 106,23 | 6,13 | 1 986 | 3 855 | |
2012-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 2 778 | 2 778 | |||||
2012-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 25 013 | 25 013 | |||||
2012-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 324 | 629 | 106,23 | 6,13 | 1 986 | 3 855 | |
2010-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 27 805 | 27 805 | |||||
2010-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 195 | 1 171 | 19,98 | 9,44 | 1 841 | 11 058 | |
2004-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 295 | 858 | 52,40 | 4,86 | 1 434 | 4 172 |